FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283526503> ?p ?o ?g. }

• W4283526503 endingPage "10" @default.
• W4283526503 startingPage "1" @default.
• W4283526503 abstract "To retrospectively evaluate the efficacy and safety of TACE combined with microwave ablation (MWA) and TACE combined with cryoablation (CRA) in the treatment of large hepatocellular carcinoma.A retrospective analysis was performed on 81 patients with large hepatocellular carcinoma (tumor diameter 5～8 cm cm) who received TACE combined with ablation in our hospital from February 2015 to February 2019. The study patients were divided into TACE combined with MWA group (T-MWA, n = 41) and TACE combined with CRA group (T-CRA, n = 40) according to the treatment plan. Overall survival (OS) and progress free survival (PFS) were compared between the two groups, and complications were observed. Survival curves for OS and PFS were constructed by the Kaplan-Meier method. Differences in overall survival were compared using the log-rank test.There was no statistical difference in general conditions between the two groups of patients. The results showed that 30 (73.2%) patients in T-MWA group achieved objective response (OR) and 39 (95.1%) patients achieved disease control (DC), compared with 24 (60.0%) patients in T-CRA group who achieved objective response (OR) and 37 (92.5%) patients who achieved disease control (DC). The median OS was 19.2 months in the T-MWA group and 18.6 months in the T-CRA group (P=0.64). The median PFS was 9.3 months in the T-MWA group and 12.3 months in the T-CRA group (P=0.6). Univariate and multivariate analysis showed that portal vein tumor thrombus (PVTT), intrahepatic tumor diameter, and the number of tumor lesions were common prognostic factors for OS and PFS. In terms of surgery-related complications and adverse reactions, abdominal pain and gastrointestinal reactions were observed in 13 (31.7%) and 11(26.8%) cases in the T-MWA group, while we observed 4 (10.0%) and 2 (5.0%) cases in the T-CRA group, respectively. The difference between the two was statistically significant (P < 0.05).TACE combined with MWA and TACE combined with CRA were equally effective in the treatment of large hepatocellular carcinoma. TACE-CRA can effectively reduce the incidence of abdominal pain and gastrointestinal reactions in patients. However, compared with TACE-MWA, TACE-CRA is more likely to cause thrombocytopenia." @default.
• W4283526503 created "2022-06-27" @default.
• W4283526503 creator A5000432967 @default.
• W4283526503 creator A5030933492 @default.
• W4283526503 creator A5034827333 @default.
• W4283526503 creator A5050319187 @default.
• W4283526503 creator A5061435763 @default.
• W4283526503 creator A5064000930 @default.
• W4283526503 creator A5068125306 @default.
• W4283526503 creator A5082421105 @default.
• W4283526503 creator A5082652766 @default.
• W4283526503 creator A5086664284 @default.
• W4283526503 date "2022-06-25" @default.
• W4283526503 modified "2023-09-27" @default.
• W4283526503 title "Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma" @default.
• W4283526503 cites W2096759906 @default.
• W4283526503 cites W2158150169 @default.
• W4283526503 cites W2324687297 @default.
• W4283526503 cites W2401804267 @default.
• W4283526503 cites W2406438510 @default.
• W4283526503 cites W2582878252 @default.
• W4283526503 cites W2605982804 @default.
• W4283526503 cites W2621809388 @default.
• W4283526503 cites W2692543478 @default.
• W4283526503 cites W2783886443 @default.
• W4283526503 cites W2890833778 @default.
• W4283526503 cites W2898568606 @default.
• W4283526503 cites W2941982624 @default.
• W4283526503 cites W2970994473 @default.
• W4283526503 cites W2992926296 @default.
• W4283526503 cites W2995084437 @default.
• W4283526503 cites W3048290729 @default.
• W4283526503 cites W3090016783 @default.
• W4283526503 cites W3091047242 @default.
• W4283526503 cites W3119213339 @default.
• W4283526503 cites W3121807241 @default.
• W4283526503 cites W3128646645 @default.
• W4283526503 cites W3138261282 @default.
• W4283526503 cites W4210774372 @default.
• W4283526503 doi "https://doi.org/10.1155/2022/9783113" @default.
• W4283526503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35795769" @default.
• W4283526503 hasPublicationYear "2022" @default.
• W4283526503 type Work @default.
• W4283526503 citedByCount "1" @default.
• W4283526503 countsByYear W42835265032022 @default.
• W4283526503 crossrefType "journal-article" @default.
• W4283526503 hasAuthorship W4283526503A5000432967 @default.
• W4283526503 hasAuthorship W4283526503A5030933492 @default.
• W4283526503 hasAuthorship W4283526503A5034827333 @default.
• W4283526503 hasAuthorship W4283526503A5050319187 @default.
• W4283526503 hasAuthorship W4283526503A5061435763 @default.
• W4283526503 hasAuthorship W4283526503A5064000930 @default.
• W4283526503 hasAuthorship W4283526503A5068125306 @default.
• W4283526503 hasAuthorship W4283526503A5082421105 @default.
• W4283526503 hasAuthorship W4283526503A5082652766 @default.
• W4283526503 hasAuthorship W4283526503A5086664284 @default.
• W4283526503 hasBestOaLocation W42835265031 @default.
• W4283526503 hasConcept C126322002 @default.
• W4283526503 hasConcept C126838900 @default.
• W4283526503 hasConcept C144301174 @default.
• W4283526503 hasConcept C167135981 @default.
• W4283526503 hasConcept C2777377203 @default.
• W4283526503 hasConcept C2777628079 @default.
• W4283526503 hasConcept C2778014663 @default.
• W4283526503 hasConcept C2778019345 @default.
• W4283526503 hasConcept C2778902805 @default.
• W4283526503 hasConcept C2989005 @default.
• W4283526503 hasConcept C38180746 @default.
• W4283526503 hasConcept C50382708 @default.
• W4283526503 hasConcept C66339696 @default.
• W4283526503 hasConcept C71924100 @default.
• W4283526503 hasConcept C90924648 @default.
• W4283526503 hasConceptScore W4283526503C126322002 @default.
• W4283526503 hasConceptScore W4283526503C126838900 @default.
• W4283526503 hasConceptScore W4283526503C144301174 @default.
• W4283526503 hasConceptScore W4283526503C167135981 @default.
• W4283526503 hasConceptScore W4283526503C2777377203 @default.
• W4283526503 hasConceptScore W4283526503C2777628079 @default.
• W4283526503 hasConceptScore W4283526503C2778014663 @default.
• W4283526503 hasConceptScore W4283526503C2778019345 @default.
• W4283526503 hasConceptScore W4283526503C2778902805 @default.
• W4283526503 hasConceptScore W4283526503C2989005 @default.
• W4283526503 hasConceptScore W4283526503C38180746 @default.
• W4283526503 hasConceptScore W4283526503C50382708 @default.
• W4283526503 hasConceptScore W4283526503C66339696 @default.
• W4283526503 hasConceptScore W4283526503C71924100 @default.
• W4283526503 hasConceptScore W4283526503C90924648 @default.
• W4283526503 hasLocation W42835265031 @default.
• W4283526503 hasLocation W42835265032 @default.
• W4283526503 hasLocation W42835265033 @default.
• W4283526503 hasOpenAccess W4283526503 @default.
• W4283526503 hasPrimaryLocation W42835265031 @default.
• W4283526503 hasRelatedWork W2079531267 @default.
• W4283526503 hasRelatedWork W2119290774 @default.
• W4283526503 hasRelatedWork W2272432385 @default.
• W4283526503 hasRelatedWork W2308063030 @default.
• W4283526503 hasRelatedWork W2614447550 @default.
• W4283526503 hasRelatedWork W2620680788 @default.

• next